Nav: Home

Cedars-Sinai launches Precision Health to deliver personalized medical care based on individual data

October 10, 2016

LOS ANGELES (Oct. 10, 2016) -- Cedars-Sinai has awarded nearly $700,000 to scientists developing new treatments and technologies -- such as advanced genetic profiling and biomedical sensors that can be worn at home -- to deliver individualized healthcare to patients.

The awards are part of a Cedars-Sinai campaign to transform its practice of medicine by harnessing advanced data on individuals' specific genes, proteins, microbiome (bacterial communities) and other body chemistry, with the goal of tailoring therapies and medications for specific patients.

Using this approach, patients one day might receive treatments as unique as their own fingerprints, based on tests that reveal their molecular makeups.

"Our goal is to drive the development of the newest technology and best research, coupled to the finest clinical practice, to rapidly deliver precise and personalized healthcare solutions," said Dermot McGovern, MD, PhD, FRCP(Lon), professor of Medicine and Biomedical Sciences and director of the campaign, known as Cedars-Sinai Precision Health.

The institutionwide effort is a partnership among scientists, clinicians and industry. The eight projects selected for funding deploy sophisticated technologies, including individualized genetic and protein profiling, high-speed culturing of bacteria, next-generation ultrasound and mobile biosensors. Using these high-tech tools, researchers are striving to forge new prevention strategies and treatments for a range of diseases and conditions, including heart disease, cancer and gastrointestinal disorders.

"Cedars-Sinai Precision Health is going to fundamentally change the way we practice medicine," said McGovern, the Joshua L. and Lisa Z. Greer Chair in Inflammatory Bowel Disease Genetics.

As one of the largest nonprofit academic medical centers in the U.S., Cedars-Sinai is in a strong position to advance this work. Its cadre of scientists, led by 350 principal investigators, is currently conducting about 1,500 bioscience studies.

While many institutions are pursuing precision healthcare strategies, Cedars-Sinai is especially suited to advance the promise of this medical revolution.

"Cedars-Sinai's flexible organizational structure, combined with its research talent and large-scale, high-quality healthcare delivery operation, make it well-qualified to achieve national prominence in the delivery of precise health solutions," said Shlomo Melmed, MD, executive vice president, Academic Affairs, and dean of the medical faculty at Cedars-Sinai. "With Cedars-Sinai Precision Health, we plan to lead the way to the newest frontier of medicine."
-end-


Cedars-Sinai Medical Center

Related Medicine Articles:

Two Baylor College of Medicine faculty members named to National Academy of Medicine
Dr. Malcolm Brenner and Dr. Cheryl Walker, both renowned leaders in their respective fields, were elected to membership in the National Academy of Medicine.
BGI and UW Medicine to collaborate on precision medicine development
BGI, one of the world's largest genomics organizations, and UW Medicine, the academic medical and health system at the University of Washington, have signed a memorandum of understanding to collaborate on biomedical technology development.
Fighting against counterfeit medicine
Around the world, especially in developing nations, counterfeit medicines are a real problem.
Proteomics and precision medicine
Researchers at the University of Iowa have used personalized proteomics to devise a successful treatment strategy for a patient with uveitis, a potentially blinding eye disease that can have many causes, making it particularly difficult to diagnose and treat effectively.
Does defensive medicine work?
In six out of seven specialties, higher-spending physicians faced fewer malpractice claims, accounting for differences in patient case-mix across physicians.
How to crowdsource the world for emergency medicine
Two new studies, published online Tuesday in Annals of Emergency Medicine, illustrate the power of social media and the Internet to promote scholarly dialogue around the world and the importance of establishing criteria for what constitutes high-quality blogs and podcasts -- 'Global Emergency Medicine Journal Club: A Social Media Discussion About the ADJUST-PE Trial' and 'Emergency Medicine and Critical Care Blogs and Podcasts: Establishing an International Consensus on Quality.'
The new frontier in plasma medicine
Applications of plasmas in medicine are a new frontier in therapeutic treatment.
Focus on geriatric medicine
The study reported by Wolfgang von Renteln-Kruse et al. (Dtsch Arztebl Int 2015; 112: 103) investigated the clinical treatment of geriatric patients with cognitive impairment, who require an appropriate environment and appropriate care.
Advanced summer school in system medicine: Implementation of systems medicine across Europe
The Coordinating Action Systems Medicine is a joint initiative of the European Commission, several European funding bodies, companies, researchers and clinicians aiming to develop a strategic roadmap for implementing Systems Medicine across Europe.
Daylight is the best medicine, for nurses
For the health and happiness of nurses -- and for the best care of hospital patients -- new Cornell research suggests exposure to natural light may be the best medicine.

Related Medicine Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...